< Back to search
Filter
1

PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer

for
Prostate Cancer
Location: Omaha NE
Sponsor: University of Nebraska

Sex: Male

Age: 30+

Code: NCT07234981

Phase2, Recruiting

Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

for
Prostate Cancer
Location: Omaha NE
Sponsor: University of Nebraska

Sex: Male

Age: 30+

Code: NCT07237269

Phase2, Recruiting

CARE Tool Study Aim 3

for
Gynecologic Cancer, Prostate Cancer, Lung Cancer,
Location: Alton IL, St Louis MO, Rolla MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07296887

Recruiting

Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

for
Clinically Significant Prostate Cancer
Location: Chicago IL
Sponsor: Xijing Hospital

Sex: Male

Age: 18+

Code: NCT07492927

Recruiting

Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer

for
Prostate Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Male

Age: 18+

Code: NCT07093177

Recruiting

Interested in new prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Fort Worth TX, West Valley City UT, Los Angeles CA
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07517198

Phase1, Recruiting

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06085729

Phase1, Phase2, Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for
Esophageal Squamous Cell Carcinoma,
Location: Lake Success NY, Fairfax VA, Sarasota FL, Detroit MI,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07503808

Phase1, Recruiting

Distance-Based Exercise to Preserve Function and Prevent Disability

for
Localized Malignant Solid Neoplasm, Anal Cancer,
Location: Boston MA, Indiana PA, Kernersville NC,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07059884

Recruiting

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

for
Metastatic Prostate Cancer, Prostate Cancer
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: Male

Age: 18+

Code: NCT07145177

Phase1, Recruiting

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer (CRPC),
Location: Madison WI
Sponsor: TechnoGenesys, Inc.

Sex: Male

Age: 18+

Code: NCT06705686

Phase1, Recruiting

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

for
Female Breast Cancer, Prostate Cancer, Colorectal Carcinoma
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 20 - 70+

Code: NCT07436078

Recruiting

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

for
Prostate Cancer, High-risk Prostate Cancer
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Male

Age: 18+

Code: NCT07027124

Phase2, Recruiting

Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)

for
Prostate Adenocarcinoma, Castration Sensitive Prostate Cancer
Location: Montreal, Hamilton
Sponsor: Ontario Clinical Oncology Group (OCOG)

Sex: Male

Age: 18+

Code: NCT06654336

Phase2, Recruiting

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

for
Prostate Cancer Screening
Location: Toronto, Vancouver
Sponsor: University of Alberta

Sex: Male

Age: 50 - 70

Code: NCT06626022

Phase3, Recruiting

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

for
Metastatic Castration-resistant Prostate Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male

Age: 18+

Code: NCT07142551

Phase2, Recruiting

Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

for
Advanced Prostate Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18+

Code: NCT06335914

Recruiting

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

for
Metastatic Breast Cancer, Metastatic Prostate Cancer
Location: Ottawa, Kitchener
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07252726

Recruiting

A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

for
Prostatic Neoplasms,
Location: Cleveland OH
Sponsor: Bayer

Sex: Male

Age: 18+

Code: NCT07406282

Recruiting

PSMA PET for Surveillance After Focal Therapy

for
Prostate Cancer (Adenocarcinoma), Prostate Cancer (Diagnosis),
Location: Chicago IL
Sponsor: University of Chicago

Sex: Male

Age: 18+

Code: NCT07115914

Recruiting